Zenas BioPharma, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.24 | 0.00 | 0.00 | 0.22 | 0.00 | 0.02 | 0.17 | |
| 0.00 | 0.53 | 0.59 | 0.88 | 0.80 | 0.00 | 0.00 | 1.03 | 0.12 | 1.20 | 0.00 | – | – | |
| 1.20 | -0.53 | -0.59 | -0.88 | -0.80 | 0.12 | 0.24 | -1.03 | -0.12 | -1.20 | 0.00 | 0.02 | -0.95 | |
| 0.22 | 0.53 | 0.59 | 0.88 | 0.80 | 1.18 | 0.84 | 1.03 | 0.82 | 4.78 | 1.09 | 1.00 | 6.02 | |
| 0.12 | 0.11 | 0.13 | 0.14 | 0.17 | 0.27 | 0.30 | 0.27 | 0.31 | 0.37 | 0.30 | 0.25 | 1.00 | |
| 0.34 | 0.11 | 0.13 | 0.15 | 0.18 | 1.45 | 1.13 | 0.29 | 1.13 | 3.92 | 1.39 | 1.72 | 6.59 | |
| 0.85 | -0.65 | -0.72 | -1.04 | -0.98 | -1.33 | -0.89 | -1.32 | -1.25 | -5.12 | -1.39 | -1.71 | -7.54 | |
| – | – | – | – | – | – | 0.00 | 0.00 | – | – | 0.12 | 0.16 | – | |
| 0.85 | -0.63 | -0.73 | -0.99 | -0.92 | -1.25 | -0.81 | -1.25 | -1.22 | -5.17 | -1.46 | -1.76 | -7.67 | |
| – | 0.01 | – | – | – | 0.01 | 0.00 | 0.00 | – | 0.00 | – | 0.00 | – | |
| 0.85 | -0.64 | -0.73 | -0.99 | -0.92 | -1.26 | -0.80 | -1.25 | -1.22 | -5.17 | -1.46 | -1.77 | -7.67 | |
| 0.85 | -0.63 | -0.72 | -0.99 | -0.92 | -1.25 | -0.81 | -1.25 | -1.22 | -4.96 | -1.34 | -1.60 | -7.25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.